HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco.

by Kimberly Page, Jennifer L Evans, Judith A Hahn, Peter Vickerman, Stephen Shiboski, Meghan D Morris
Published 2019-01-01

Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships.

by Meghan D Morris, Erin Andrew, Judy Y Tan, Lisa Maher, Colleen Hoff, Lynae Darbes, Kimberly Page
Published 2019-01-01

Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.

by Meghan D Morris, Jennifer Evans, Martha Montgomery, Michelle Yu, Alya Briceno, Kimberly Page, Judith A Hahn
Published 2014-01-01

Progress toward closing gaps in the hepatitis C virus cascade of care for people who inject drugs in San Francisco.

by Ali Mirzazadeh, Yea-Hung Chen, Jess Lin, Katie Burk, Erin C Wilson, Desmond Miller, Danielle Veloso, Willi McFarland, Meghan D Morris
Published 2021-01-01

Correction: Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.

by Shelley N Facente, Eduard Grebe, Katie Burk, Meghan D Morris, Edward L Murphy, Ali Mirzazadeh, Aaron A Smith, Melissa A Sanchez, Jennifer L Evans, Amy Nishimura, Henry F Raymond, End Hep C SF
Published 2018-01-01

Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.

by Shelley N Facente, Eduard Grebe, Katie Burk, Meghan D Morris, Edward L Murphy, Ali Mirzazadeh, Aaron A Smith, Melissa A Sanchez, Jennifer L Evans, Amy Nishimura, Henry F Raymond, End Hep C SF
Published 2018-01-01